Veru, Inc. (VERU)
2.51
-0.03
(-1.18%)
USD |
NASDAQ |
Oct 02, 16:00
2.525
+0.02
(+0.60%)
After-Hours: 20:00
Veru Enterprise Value : 19.69M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 19.69M |
| October 01, 2026 | 20.20M |
| September 30, 2026 | 22.25M |
| September 29, 2026 | 20.54M |
| September 28, 2026 | 19.94M |
| September 25, 2026 | 20.20M |
| September 24, 2026 | 19.69M |
| September 23, 2026 | 18.84M |
| September 22, 2026 | 19.52M |
| September 21, 2026 | 18.49M |
| September 18, 2026 | 17.98M |
| September 17, 2026 | 17.64M |
| September 16, 2026 | 16.45M |
| September 15, 2026 | 16.79M |
| September 14, 2026 | 16.79M |
| September 11, 2026 | 18.49M |
| September 10, 2026 | 19.52M |
| September 09, 2026 | 19.18M |
| September 08, 2026 | 20.88M |
| September 04, 2026 | 21.90M |
| September 03, 2026 | 22.07M |
| September 02, 2026 | 23.78M |
| September 01, 2026 | 22.76M |
| August 31, 2026 | 24.63M |
| August 28, 2026 | 21.65M |
| Date | Value |
|---|---|
| August 27, 2026 | 23.61M |
| August 26, 2026 | 24.63M |
| August 25, 2026 | 23.10M |
| August 24, 2026 | 21.05M |
| August 21, 2026 | 21.90M |
| August 20, 2026 | 20.88M |
| August 19, 2026 | 21.90M |
| August 18, 2026 | 21.05M |
| August 17, 2026 | 21.73M |
| August 14, 2026 | 23.44M |
| August 13, 2026 | 22.93M |
| August 12, 2026 | 23.61M |
| August 11, 2026 | 24.46M |
| August 10, 2026 | 24.12M |
| August 07, 2026 | 16.62M |
| August 06, 2026 | 16.28M |
| August 05, 2026 | 16.62M |
| August 04, 2026 | 17.30M |
| August 03, 2026 | 15.43M |
| July 31, 2026 | 15.08M |
| July 30, 2026 | 14.74M |
| July 29, 2026 | 14.57M |
| July 28, 2026 | 14.91M |
| July 27, 2026 | 15.77M |
| July 24, 2026 | 15.25M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.893B |
| Corcept Therapeutics, Inc. | 12.24B |
| Johnson & Johnson | 644.86B |
| Eli Lilly & Co. | 1.122T |
| Lexicon Pharmaceuticals, Inc. | 678.42M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -6.988M |
| Total Expenses (Quarterly) | 6.988M |
| EPS Diluted (Quarterly) | -0.3032 |
| Earnings Yield | -24.34% |
| Normalized Earnings Yield | -29.64 |